Adicet Bio ACET Cash Flow Statement (2017-2026)

NASDAQ ACET
$2.99 -0.01 (-0.33%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Adicet Bio Quarterly Cash Flow Statement

Periods 39 quarters
Latest Sep 2026

Adicet Bio reported cash from operations of -$17.92M and free cash flow of -$17.98M for the quarter ended Sep 2026, up 19.7% year over year. This cash flow statement covers 39 quarters of results from Mar 2017 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-15.81M4.62M-22.54M-22.00M-30.88M-32.40M-49.89M-29.49M-28.02M-29.90M-30.48M-28.73M-28.21M-31.22M-26.86M-30.52M-20.24M-21.36M-18.88M
Depreciation and DepletionDep. & Depletion
1.65M1.60M1.59M1.68M1.66M1.57M1.34M1.20M1.04M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.02M0.02M0.02M0.01M0.00M0.00M0.04M0.02M0.03M
Depreciation & Amortization (CF)Dep. & Amort.
0.34M0.40M0.40M0.80M1.25M1.50M1.60M1.69M1.70M1.60M1.60M1.66M1.60M1.60M1.60M1.49M1.34M1.20M1.00M
Share-based CompensationStock Comp.
4.28M4.35M4.34M4.19M4.77M5.02M5.56M4.95M5.70M6.00M1.60M1.60M3.20M2.91M2.53M3.10M1.30M1.44M1.51M
Cash from Discontinued OperationsCash from Discont. Ops
-24.09M-24.90M-21.24M-23.49M-22.85M-23.42M-22.01M-24.10M-25.40M-26.63M-22.31M-21.49M-19.82M-17.92M
Gains from Sales and DivestituresGains Divest
0.16M-0.02M0.00M
Asset Writedowns and ImpairmentWritedown
Other non-cash itemsOther Non-Cash
0.33M0.65M0.56M0.77M0.75M0.76M0.78M0.79M0.81M0.82M0.85M0.83M0.68M1.03M0.74M0.76M0.66M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.03M0.19M
Change in Account PayablesChange Payables
-1.94M-0.61M-2.33M0.71M1.40M-1.46M-0.21M-0.57M0.73M1.15M0.63M-1.12M1.21M0.31M-1.80M0.66M-0.89M
Change in Accrued ExpensesChange Accrued Exp.
1.97M-1.50M-0.25M0.27M0.02M0.71M-1.78M0.98M-0.33M-0.89M-2.20M1.63M0.54M1.93M-1.15M-0.75M-0.16M
Change in Other Operating AssetsOther Assets Change
-2.19M-1.38M-0.30M-0.07M-0.66M-0.26M0.11M1.43M-0.12M-0.50M-0.86M-0.44M0.50M-1.20M0.08M0.10M-0.08M
Change in Other Operating LiabilitiesOther Liabilities Change
-4.69M-5.17M2.47M-0.86M-0.85M-0.87M-0.89M-0.90M-0.93M-0.97M-0.99M-0.89M-0.78M-0.80M-0.82M-1.04M-0.78M
Other Working Capital ChangesOther WC Changes
-2.50M-3.79M2.77M-0.79M-0.19M-0.61M-1.00M-2.33M-0.81M-0.47M-0.13M-0.45M-1.28M0.40M-0.90M-1.14M-0.70M
Cash from OperationsCash from Ops.
-13.44M4.11M-24.09M-24.90M-21.24M-23.49M-22.85M-23.42M-22.01M-24.10M-25.40M-26.63M-22.31M-20.91M-21.49M-19.82M-17.92M
Investing Activities
Capital ExpendituresCapex
3.08M2.63M1.92M1.51M0.91M0.14M0.24M0.30M0.40M0.18M1.49M0.05M0.21M-0.01M0.04M0.20M0.06M
Change in Property, Plant and EquipmentChange in PP&E
-3.08M-2.63M-1.92M-1.51M-0.91M-0.14M-0.24M-0.30M-0.40M-0.18M-1.49M-0.05M-0.21M0.01M-0.04M-0.20M-0.06M
Purchase of InvestmentsInvestments Purchased
Sale and Maturity of InvestmentsInvestments Sold
Other Investing Activities (as filed)Other investing (as filed)
-4.38M0.15M-1.92M-1.51M-0.91M4.33M2.90M2.90M-0.03M2.87M-0.30M
Cash from Investing ActivitiesCash from Investing
-3.08M-2.63M-1.92M-1.51M-0.91M-0.14M-0.24M-0.30M-96.58M-22.12M-2.86M32.95M16.84M-44.54M18.88M16.65M11.60M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Net Long-Term Debt Issued (Repaid)Net LT Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
97.57M0.09M0.00M0.23M0.16M111.11M0.20M0.14M0.27M75.23M0.00M
Net Shares Issued and RepurchasedNet Shares Issued
97.57M0.09M0.00M0.23M0.16M111.11M0.20M0.14M0.27M75.23M0.00M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
97.57M0.09M0.00M0.23M0.16M111.11M0.20M0.14M0.27M75.23M0.00M
Other financing activities (as filed)
-0.11M-1.11M-0.20M-1.36M-0.01M0.01M-0.06M-0.15M-0.14M-0.10M0.10M-0.10M-0.07M0.00M
Cash from Financing ActivitiesCash from Financing
97.46M-1.13M-0.01M0.23M-0.06M0.08M110.97M0.20M0.14M-0.10M0.27M-0.15M75.23M-0.07M0.06M0.00M
Additional items
Change in Cash
80.94M0.34M-26.02M-26.18M-22.20M-23.55M87.88M-23.52M-118.59M-46.08M-28.36M6.59M-5.62M9.79M-2.68M-3.11M-6.32M
Beginning Cash Balance
88.86M277.69M277.69M277.69M277.69M257.66M257.66M257.66M
Ending Cash Balance
277.69M278.03M260.64M282.68M257.66M231.64M205.46M183.26M159.71M247.59M224.07M105.48M59.40M31.04M37.62M32.00M41.79M39.11M36.00M29.69M
Free Cash FlowFCF
-16.52M1.47M-26.01M-26.41M-22.14M-23.62M-23.09M-23.72M-22.41M-24.28M-26.89M-26.68M-22.52M-20.90M-21.53M-20.03M-17.98M
Net Cash FlowNCF
80.94M0.34M-26.02M-26.18M-22.20M-23.55M87.88M-23.52M-118.59M-46.08M-28.36M6.59M-5.62M9.79M-2.68M-3.11M-6.32M
Income Taxes PaidTaxes Paid
-0.17M

Adicet Bio Cash Flow Statement API

Pull Adicet Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ACET&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY